Welcome to our dedicated page for Plexus SEC filings (Ticker: PLXS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Plexus Corp (NASDAQ: PLXS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Plexus files periodic and current reports as a Wisconsin corporation with Commission File Number 001-14423.
Among the key documents available are current reports on Form 8-K, which Plexus uses to furnish press releases announcing quarterly and annual financial results. These filings typically include information on revenue, operating margin, earnings per share, non-GAAP performance measures, return on invested capital, free cash flow and other financial metrics, as well as commentary on business conditions and program wins.
Through this page, users can track how Plexus reports its results for fiscal quarters and years, including references to its geographic segments in the Americas, Asia-Pacific and Europe, Middle East and Africa regions, and its focus on Aerospace/Defense, Healthcare/Life Sciences and Industrial market sectors. Filings also confirm corporate details such as state of incorporation and principal corporate location.
Stock Titan enhances these filings with AI-powered summaries that highlight the most important points from lengthy documents, helping readers quickly understand the implications of each report. Real-time updates from the SEC’s EDGAR system, along with structured access to forms such as 8-K and other periodic reports, make it easier to review Plexus’ regulatory history and monitor ongoing disclosures related to PLXS.
Plexus Corp (PLXS) insider sale by Victor Tan. The filing shows that Victor Tan, Regional President - APAC and a reporting person, sold a total of 3,000 shares on 08/28/2025 in two transactions: 2,000 shares at a weighted-average price reported as $138.75 and 1,000 shares at $139.50. After these dispositions the filing reports Mr. Tan beneficially owns 8,723 shares. The form notes the 2,000-share sale was executed in multiple trades at prices ranging from $138.50 to $139.00 and that the reported price is the weighted average. The form is signed by an attorney-in-fact on 08/29/2025.
Plexus Corp (PLXS) insider transaction by Executive Vice President & Chief Financial Officer Patrick J. Jermain. The filing shows a sale of 2,500 shares of Common Stock on 08/27/2025 at $137.71 per share. After the sale, the reporting person beneficially owned 20,959 shares in total. The report also discloses 3,719 shares held indirectly in the Plexus 401(k) plan per trustee records. The Form 4 was submitted individually and signed by an attorney-in-fact on 08/29/2025. The document contains only the disclosed trade and holdings; no additional context or explanations are provided.
Plexus Corp (PLXS) Form 144 notice: A proposed sale of 3,000 shares of common stock is reported through Morgan Stanley Smith Barney LLC, with an aggregate market value of $417,000 and approximately 26,986,726 shares outstanding. The approximate date of sale is 08/28/2025 on NASDAQ. The securities were acquired from the issuer as restricted stock and performance shares on 01/27/2023 (1,480 shares), 01/25/2024 (155 shares), and 02/13/2024 (1,365 shares). No securities of the issuer were reported sold by the person in the past three months, and the filer certifies they are not aware of undisclosed material adverse information.
Plexus Corp (PLXS) insider sale disclosed. Angelo M. Ninivaggi Jr., listed as Director and Executive Vice President/CAO/General Counsel & Secretary, sold 1,576 shares of Plexus common stock on 08/25/2025 at a price of $137.775 per share. After the transaction he beneficially owned 24,495 shares. The Form 4 was signed by an attorney-in-fact on 08/27/2025.
Plexus Corp (PLXS) Form 144 - A holder has filed notice to sell 2,500 shares of Plexus common stock on or about 08/27/2025, with an aggregate market value of $344,275.00 based on the filing. The securities were acquired as performance shares on 02/12/2019. The filing states there are 26,986,726 shares outstanding and lists the proposed broker as Morgan Stanley Smith Barney LLC on NASDAQ. The notice also reports that Patrick Jermain sold 2,178 shares on 08/06/2025 for gross proceeds of $284,054.76. The filer certifies they are not aware of undisclosed material adverse information.
Plexus Corp (PLXS) Form 144 notice shows a proposed sale of 1,576 common shares through Morgan Stanley Smith Barney on 08/25/2025 with an aggregate market value of $217,133.40. The shares were acquired as performance shares from the issuer on 02/13/2024. The filing also reports a prior sale by Angelo M. Ninivaggi of 2,058 common shares on 05/27/2025 for gross proceeds of $272,112.88. The issuer's total shares outstanding are reported as 26,986,726, and the proposed sale lists NASDAQ as the exchange. The filer certifies no undisclosed material adverse information is known.
Oliver K. Mihm, Executive Vice President & Chief Operating Officer of Plexus Corp. (PLXS), reported changes in his beneficial ownership in a Form 4 filing. The filing shows 981 shares held indirectly in the Plexus 401(k) plan, a sale of 2,102 shares on 08/15/2025 at $130.43 per share, and a gift of 200 shares on 08/18/2025. After the reported transactions, Mihm beneficially owned 20,955 shares directly.
The filing states the 981 shares were held in the company 401(k) plan per the plan trustee and that the 200 shares were given as a bona fide gift. The form was signed on behalf of Mihm by an attorney-in-fact on 08/19/2025. No derivative transactions or option exercises are listed.
Plexus Corporation (PLXS) Form 144: A notice of proposed sale reports 2,102 common shares to be sold through Morgan Stanley Smith Barney LLC on NASDAQ with an approximate sale date of 08/15/2025. The filing lists an aggregate market value of $274,163.86 and 26,986,726 shares outstanding. The shares were acquired as performance shares on 11/16/2023 from the issuer and were fully paid on that date. The filer reports no securities sold in the past three months. The notice includes the standard signer representation that the selling person is not aware of any undisclosed material adverse information about the issuer.
Plexus Corp (PLXS) officer reported an insider sale and existing plan holdings. The Form 4 shows an 08/06/2025 sale of 2,178 shares of Plexus common stock at $130.42 per share. After that disposition the reporting person is shown as directly owning 23,459 shares. The filing also discloses 3,719 shares held indirectly in the Plexus 401(k) Retirement Plan per the plan trustee.
The reporting person is identified as an officer serving as Executive Vice President & Chief Financial Officer. No derivative securities or option transactions are reported. The Form 4 is signed by the reporting person via an attorney-in-fact.